LP220249-9

Ledipasvir

Active

Description

Ledipasvir is a hepatitis C virus (HCV) NS5A inhibiting antiviral drug for the treatment of HCV. It is used in combination with sofosbuvir, and approved by the FDA for the treatment of chronic hepatitis C genotype 1 infection in adults. PMID: 26788571 Source: Regenstrief LOINC

Basic Part Properties

Part Display Name: Ledipasvir
Part Type: Component (Describes the core component or analyte measured)
Created On: 2016-06-24
Construct for LOINC Short Name: Ledipasvir

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP220249-9

Language Variants Get Info

Tag	Language	Translation
zh-CN	Chinese (China)	雷迪帕韦 Synonyms: GS 588;CAS 1256388-51-8;Methyl [(2S)-1-[(6S)-6-[4-(9,9-difluoro-7-[2-[(1S,3S,4R)-2-[(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]-2-azabicyclo[2.2.1]hept-3-yl]-1H-benzimidazol-5-yl]-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]-3-meth
es-ES	Spanish (Spain)	Ledipasvir
it-IT	Italian (Italy)	Ledipasvir
nl-NL	Dutch (Netherlands)	ledipasvir

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.